Bladder Cancer
Determining the clinicopathological significance of the VI-RADS ≧4 group: a retrospective study.
March 22, 2024
A Genomic Urine Assay for Surveillance of Patients with Bladder Cancer Treated with Radiotherapy.
March 21, 2024
The impact of perioperative risk factors on long-term survival after radical cystectomy: a prospective, high-volume cohort study.
March 20, 2024
Patterns of treatment of high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) patients among Arab urologists.
March 20, 2024
Addition of neoadjuvant chemotherapy to a 'quadrifecta' composite in radical cystectomy.
March 18, 2024
Characterization of Targets for Antibody-Drug Conjugates in Advanced Urothelial Carcinoma - Expert Commentary
March 15, 2024
Alignment of molecular subtypes across multiple bladder cancer subtyping classifiers.
March 15, 2024
Efficacy of cytoreductive radical cystectomy in metastatic urothelial bladder cancer based on site and number of metastases.
March 15, 2024
The optimal number of induction chemotherapy cycles in clinically lymph node-positive bladder cancer.
March 14, 2024